STOCK TITAN

Insider proposes sale of 8,149 DTIL shares (NASDAQ: DTIL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DTIL insider John A. Kelly filed a Form 144 reporting a proposed sale of 8,149 common shares that vested as restricted stock on 02/17/2026, handled through Fidelity Brokerage Services LLC. The filing also discloses a prior sale of 15,213 common shares on 01/21/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows a proposed sale of 8,149 DTIL shares by John A. Kelly following restricted stock vesting.

The filing lists 8,149 common shares tied to restricted stock vesting on 02/17/2026 and handled via Fidelity Brokerage Services LLC. This is a disclosure of a proposed sale rather than an executed market transaction.

It also records a prior sale of 15,213 shares on 01/21/2026. Subsequent confirmations of execution or proceeds would appear in later filings.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the DTIL Form 144 filed by John A. Kelly report?

The filing reports a proposed sale of 8,149 common shares that vested as restricted stock on 02/17/2026. It also notes a prior sale of 15,213 shares on 01/21/2026, with transactions routed through Fidelity.

How many DTIL shares vested for the insider on 02/17/2026?

The filing indicates 8,149 common shares vested as restricted stock on 02/17/2026. These vested shares are the quantity listed for the proposed sale in the Form 144 disclosure handled via Fidelity Brokerage Services LLC.

Did John A. Kelly sell DTIL shares recently before this Form 144?

Yes. The Form 144 records a sale of 15,213 common shares on 01/21/2026. That prior transaction is included in the filing’s "Securities Sold During The Past 3 Months" section alongside the proposed sale.

Through which broker will the proposed DTIL sale be executed?

The filing lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI, as the broker-dealer associated with the proposed sale. The Form 144 ties the sale logistics to that brokerage for the disclosed shares.

Does the Form 144 confirm the sale was completed?

No. The Form 144 reports a proposed sale of 8,149 vested shares on 02/17/2026; it does not confirm execution. A subsequent filing would report completion or actual proceeds if the sale occurred.
Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

96.05M
22.56M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
DURHAM